Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Understanding pathophysiology and identifying mothers at risk of major pregnancy complications is vital to effective prevention and optimal management. However, in current antenatal care, understanding of pathophysiology of complications is limited. In gestational diabetes mellitus (GDM), risk prediction is mostly based on maternal history and clinical risk factors and may not optimally identify high risk pregnancies. Hence, universal screening is widely recommended. Here, we will explore the literature on GDM and biomarkers including inflammatory markers, adipokines, endothelial function and lipids to advance understanding of pathophysiology and explore risk prediction, with a goal to guide prevention and treatment of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 2×
“GDM is a condition of carbohydrate intolerance with onset or first recognition in pregnancy [44].”
BackgroundClassification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · cited 1×
“Increased FFAs from enlarged adipocytes act as ligands for toll-like receptors (TLRs) and induce production of inflammatory cytokines from macrophages through activation of the nuclear factor-κB (NF-κB) pathway, which has been shown to be related to insulin resistance [17,21,22].”
BackgroundEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“Randomised controlled trials (RCTs) have demonstrated improved maternal and neonatal outcomes with subsequent treatment of GDM [50,51].”
BackgroundCriteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924 · cited 5×
“Coustan criteria [64] 21–27 week Adiponectin 10 μg/mL has sensitivity of”
BackgroundInfluentialMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Challis, J. R., Lockwood, C. J., Myatt, L., Norman, J. E., Strauss, J. F., & Petraglia, F. (2009) · Reproductive Sciences · doi:10.1177/1933719108329095 · Cited by 893
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788 · cited 1×
“This is supported by cross-sectional [23–28] and prospective [25,29–33] studies of associations between increased markers of inflammation and obesity, insulin resistance and/or T2DM.”
ResultTNF-α Is a Predictor of Insulin Resistance in Human Pregnancy
Kirwan, J. P., Hauguel-De Mouzon, S., Lepercq, J., Challier, J.-C., Huston-Presley, L., Friedman, J. E., Kalhan, S. C., & Catalano, P. M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2207 · Cited by 738 · cited 3×
“However, the correlation was no longer significant when adjusted for fat mass [63].”
BackgroundInfluentialAghajafari, F., Nagulesapillai, T., Ronksley, P. E., Tough, S. C., O'Beirne, M., & Rabi, D. M. (2013) · BMJ · doi:10.1136/bmj.f1169 · Cited by 727
Sacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1641 · Cited by 687 · cited 1×
“5%) using International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria [46].”
MethodIncreased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489
Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial
Dodd, J. M., Turnbull, D., McPhee, A. J., Deussen, A. R., Grivell, R. M., Yelland, L. N., Crowther, C. A., Wittert, G., Owens, J. A., Robinson, J. S., et al. (2014) · BMJ · doi:10.1136/bmj.g1285 · Cited by 482 · cited 1×
“However, the LIMIT randomised trial (Limiting weight gain in overweight and obese women during pregnancy to improve health outcomes) in Australia including over 2000 overweight and obese pregnant women found that antenatal dietary and lifestyle advice did not reduce the risk of large for gestational age (LGA) or impro…”
BackgroundInflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance
Shoelson, S. E., Lee, J., & Yuan, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802501 · Cited by 474
Inflamed fat: what starts the fire?
Neels, J. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27280 · Cited by 463 · cited 1×
“Cellular mechanisms responsible for enhanced macrophage recruitment in obesity are largely unknown, but increased adipocyte size and dysregulated adipokine production promote cross-talk between adipocytes and macrophages [19].”
BackgroundThe Role of Oxidative Stress in the Pathophysiology of Gestational Diabetes Mellitus
Lappas, M., Hiden, U., Desoye, G., Froehlich, J., Mouzon, S. H.-D., & Jawerbaum, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3765 · Cited by 442 · cited 1×
“Pathologic pregnancies including GDM are associated with heightened levels of oxidative stress due to overproduction of free radicals (leading to abnormal mitochondrial function) and defects in antioxidant defences [59].”
BackgroundSchaefer-Graf, U. M., Graf, K., Kulbacka, I., Kjos, S. L., Dudenhausen, J., Vetter, K., & Herrera, E. (2008) · Diabetes Care · doi:10.2337/dc08-0039 · Cited by 439 · cited 3×
“[137] performed a prospective study of 150 women looking at maternal lipids including serum TG, cholesterol, free fatty acids (FFA), glycerol, insulin and glucose in maternal serum and cord blood during the third trimester.”
BackgroundInfluentialThe Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
HAPO Study Cooperative Research Group (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00092-9 · Cited by 401
Modulation of adipokines and cytokines in gestational diabetes and macrosomia
Atègbo, J.-M., Grissa, O., Yessoufou, A., Hichami, A., Dramane, K. L., Moutairou, K., Miled, A., Grissa, A., Jerbi, M., Tabka, Z., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0980 · Cited by 398 · cited 3×
“Most cross-sectional studies show that circulating TNF-α concentrations are increased in the second and third trimesters [14], correlate with pre-pregnancy BMI [88,89] and predict insulin resistance and GDM [14,88,90].”
BackgroundLeptin, adiponectin and other adipokines in gestational diabetes mellitus and pre‐eclampsia
Miehle, K., Stepan, H., & Fasshauer, M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04234.x · Cited by 236 · cited 10×
“This may relate to the strong associations of RBP-4, BMI and insulin resistance [42].”
BackgroundInfluentialAdipokines in gestational diabetes
Fasshauer, M., Blüher, M., & Stumvoll, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70176-1 · Cited by 230
Obesity, pregnancy, inflammation, and vascular function
Denison, F. C., Roberts, K. A., Barr, S. M., & Norman, J. E. (2010) · Reproduction · doi:10.1530/rep-10-0074 · Cited by 221 · cited 7×
“In obese individuals, there is an increase in macrophage density and a shift toward the M1 “classically activated” phenotype (probably driven by T-helper-1 (Th-1) cytokines), secreting pro-inflammatory cytokines such as tumour necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and interleukin-12 (IL-12) and generatin…”
BackgroundInfluentialWilliams, M. A., Qiu, C., Muy-Rivera, M., Vadachkoria, S., Song, T., & Luthy, D. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031201 · Cited by 220
Vitamin D and Gestational Diabetes: A Systematic Review and Meta-Analysis
Poel, Y. H. M., Hummel, P., Lips, P., Stam, F., van der Ploeg, T., & Simsek, S. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.01.007 · Cited by 211 · cited 1×
“Three recent systematic reviews [126–128] concluded that 25-OHD deficiency was associated with higher risk of GDM.”
BackgroundDiabetes and beta cell function: from mechanisms to evaluation and clinical implications
Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203 · cited 1×
“Mitochondrial dysfunction due to oxidative damage has an important role in pathogenesis of chronic metabolic diseases characterized by insulin resistance, such as metabolic syndrome and T2DM [58].”
BackgroundScreening for biomarkers predictive of gestational diabetes mellitus
Georgiou, H. M., Lappas, M., Georgiou, G. M., Marita, A., Bryant, V. J., Hiscock, R., Permezel, M., Khalil, Z., & Rice, G. E. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0037-8 · Cited by 151
Increased Maternal Plasma Leptin in Early Pregnancy and Risk of Gestational Diabetes Mellitus
Qiu, C., Williams, M. A., Vadachkoria, S., Frederick, I. O., & Luthy, D. A. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113621.53602.7a · Cited by 146 · cited 2×
“There was a strong linear correlation, with each 10 ng/mL increase in leptin concentration associated with a 20% increase in GDM risk, independent of maternal pre-pregnancy adiposity and other confounders (see Table 1) [75].”
BackgroundMolecular Mechanisms of Diabetes and Atherosclerosis: Role of Adiponectin
Kishida, K., Funahashi, T., & Shimomura, I. (2012) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153012800493468 · Cited by 78
Kramer, C. K., Swaminathan, B., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2341 · Cited by 52 · cited 6×
“Another RCT of women with 25-OHD levels 80 nmol/L at mean 14 weeks gestation randomised to high dose 25-OHD (5000 IU daily) vs. routine pregnancy dosages (400 IU daily) until delivery, found no difference in maternal glucose levels on OGTT [131].”
BackgroundInfluential
Cited by
Pellonperä, O., Mokkala, K., Houttu, N., Vahlberg, T., Koivuniemi, E., Tertti, K., Rönnemaa, T., & Laitinen, K. (2019) · Diabetes Care · doi:10.2337/dc18-2591 · Cited by 145
Pathirana, M. M., Ali, A., Lassi, Z. S., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2022) · Journal of Human Lactation · doi:10.1177/08903344211034779 · Cited by 29
Non-pharmacological management of gestational diabetes: The role of myo-inositol
Guardo, F. D., Currò, J. M., Valenti, G., Rossetti, P., Di Gregorio, L. M., Conway, F., Chiofalo, B., Garzon, S., Bruni, S., & Rizzo, G. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0111 · Cited by 14
“In addition, tumor necrosis factor-α (TNF-α) influences hyperglycemia, thus interfering with insulin receptor signaling and β-cell function [18, 22].”
BackgroundBiomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility
Pramodkumar, T. A., Hannah, W., Anjana, R. M., Ram, U., Tiwaskar, M., Gokulakrishnan, K., Popova, P. V., & Mohan, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0849 · Cited by 7
“70,47 CRP, through its interaction with endothelial cells, promotes vascular inflammation, oxidative stress, and dysregulation of insulin signaling pathways.”
Metadata
- Authors
- Abell, S., De Courten, B., Boyle, J., & Teede, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-06-11
- Volume
- 16
- Issue
- 6
- Pages
- 13442-13473
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2164974383
- Cited by
- 239
- References
- 33
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.